For several decades, veterinary vaccines have played a key role in improving food security and as a result, human health. The medicine sphere wherein veterinary medicines constitute a significant share continues to evolve at a consistent pace. At present, innovations in the veterinary therapeutics market are largely made possible through advancements in technology and research & development activities. Over the past decade, a considerable amount of promising breakthroughs in the veterinary therapeutic field have paved the way for a host of specialty medicine. The significant rise in the number of pet animals worldwide, progress in surgical and medical capabilities pertaining to the treatment of animals, growing focus on improving the overall wellness of animals, significant progress in the development of new vaccines for an array of diseases, and discovery of new medication to curb the occurrence of new diseases are some of the key factors expected to influence the expansion of the veterinary therapeutics market during the forecast period.
Companies involved in the current veterinary therapeutics market landscape are actively engaged in research and development activities that have offered considerable promise. However, one of the glaring challenges that market participants are required to negotiate their way through is the evolving regulatory framework. Product development is likely to remain the cornerstone of the growth of the global veterinary therapeutics market, which is expected to reach US$ 58.5 Bn mark by the end of 2027.
Veterinary therapeutics have evolved at a considerable pace over the past decade, as drug developers continue to improve the overall efficacy of their products. Moreover, cost-efficiency, ease of administration, and suitability for mass vaccination are some of the other areas that have gained a great amount of consideration during the drug development phase. In recent times, DNA vaccines have offered significant promise as an ideal solution for different poultry diseases, as they have exhibited no reversion to virulence and infection. At present, DNA vaccines have started to gain a great amount of traction, as they can be deployed against an array of pathogens and are comparatively easier to develop, manufacture, and store. However, despite offering these advantages, the adoption of DNA vaccines could slow down, owing to lack of capacity to induce high immunity and lack of availability for large-scale vaccination in the current scenario.
Vaccines and the development of new drugs will continue to progress at a consistent pace during the forecast period. Presently, in terms of product type, drugs are set to retain the majority of the share of the veterinary therapeutics market– a trend that is expected to continue during the forecast period. Although drugs will remain popular, the development of new vaccines will gain considerable momentum. DNA vaccines to address diseases in poultry are predominantly for combating bacterial, viral, and protozoan diseases. Although DNA vaccines to tackle poultry diseases have gained momentum since 1993, FDA approval for these vaccines has gathered pace only in the past decade. Clinical trials and added research and development activities will continue to boost the adoption of vaccines within the global veterinary therapeutics market in the coming years.
Companies operating in the current veterinary therapeutics market are expected to increase their market share by relying on inorganic growth strategies such as mergers & acquisitions. While expanding the product portfolio will continue to be an integral part of growth strategies for participants operating in the current market landscape, commercialization and development of new veterinary therapeutics are expected to gain momentum. For instance, in July 2019, Elanco Animal Health Incorporated announced that the company has completed the acquisition of Aratana Therapeutics. With the acquisition, Elanco could expand its product portfolio and gain the exclusive rights to manufacture, develop, and commercialize the ‘cash cow’ Galliprant. While drug development will continue to revolve around companion animals as well as livestock animals, market participants are anticipated to continue to improve the efficacy of their veterinary therapeutics during the forecast period.
Analysts’ Viewpoint
The global veterinary therapeutics market is expected to grow at a CAGR of 5.6% during the forecast period. Some of the major factors that are likely to propel the market growth include growing demand for improved drugs, rise in the number of companion animals worldwide, improvements in surgical and medical capabilities of treatments for companion animals, development of products to combat new diseases, and growing emphasis on wellness and prevention of diseases in animals. Companies operating in the current market landscape should focus on expanding their product portfolio, investing in the development of DNA vaccines, and adopting inorganic growth strategies, including mergers & acquisitions to gain steady ground in the veterinary therapeutics market.
Veterinary Therapeutics Market - Segmentation
TMR’s study on the global veterinary therapeutics market includes information divided into four segments: product type, animal, route of administration, distribution channel, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global veterinary therapeutics market are discussed in detail.
|
Product Type |
Drugs
Vaccines
Medicated Feed Additives
|
|
Animal |
Companion Animal Livestock Animal |
|
Route of Administration |
Oral Parenteral Topical |
|
Distribution Channel |
Veterinary Hospitals Veterinary Clinics Pharmacies & Drug Stores Others |
|
Region |
North America Europe Asia Pacific Latin America Middle East & Africa |
Veterinary therapeutics market is expected to reach US$ 58.5 Bn mark by the end of 2027
Veterinary therapeutics market is expected to grow at a CAGR of 5.6% during 2019 - 2027
Veterinary therapeutics market is driven by rise in demand for high quality protein
North America accounted for a major share of the global veterinary therapeutics market and the trend is anticipated to continue during the forecast period
Key players in the global veterinary therapeutics market include Zoetis, Inc., Merck Animal Health, Elanco Animal Health, and Boehringer Ingelheim GmbH, Ceva Santé Animale
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Research Methodology
3. Executive Summary
3.1. Global Veterinary Therapeutics Market Snapshot
4. Market Overview
4.1. Product Overview
4.2. Key Industry Events
4.3. Market Dynamics
4.3.1. Drivers and Restraints Snapshot Analysis
4.3.2. Drivers
4.3.3. Restraints
4.3.4. Opportunities
4.4. Porter’s Five Forces Analysis
4.5. Value Chain Analysis
4.6. Global Veterinary Therapeutics Market Outlook
5. Market Outlook
5.1. U.S. Pet Ownership Statistics, 2017
5.2. Cat and Dog Annual Expenditures, 2017
5.3. United States Pet Expenditures
6. Global Veterinary Therapeutics Market Analysis, by Product Type
6.1. Key Findings
6.2. Introduction
6.3. Global Veterinary Therapeutics Market Value Share Analysis, by Product Type
6.4. Global Veterinary Therapeutics Market Forecast, by Product Type
6.4.1. Drugs
6.4.2. Vaccines
6.4.3. Medicated Feed Additives
6.5. Global Veterinary Therapeutics Market Analysis, by Product Type
6.6. Global Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
6.6.1. Anti-infective
6.6.2. Anti-inflammatory
6.6.3. Parasiticides
6.6.4. Others
6.7. Global Veterinary Therapeutics Market Analysis, by Drugs
6.8. Global Veterinary Therapeutics Market Forecast, by Vaccines, 2017–2027
6.8.1. Inactivated Vaccines
6.8.2. Live Attenuated Vaccines
6.8.3. Recombinant Vaccines
6.8.4. Others
6.9. Global Veterinary Therapeutics Market Analysis, by Vaccines
6.10. Global Veterinary Medicated Feed Additives Market Forecast, by Medicated Feed Additives
6.10.1. Antibiotics
6.10.2. Amino Acids
6.10.3. Others
6.11. Global Veterinary Medicated Feed Additives Market Analysis, by Medicated Feed Additives
6.12. Global Veterinary Therapeutics Market Attractiveness Analysis, by Product Type
6.13. Key Trends
7. Global Veterinary Therapeutics Market Analysis, by Animal
7.1. Key Findings
7.2. Introduction
7.3. Global Veterinary Therapeutics Market Value Share Analysis, by Animal
7.4. Global Veterinary Therapeutics Market Forecast, by Animal
7.4.1. Companion Animal
7.4.2. Livestock Animal
7.5. Veterinary Therapeutics Market Forecast, by Animal
7.6. Veterinary Therapeutics Market Attractiveness Analysis, by Animal
7.7. Key Trends
8. Veterinary Therapeutics Market Analysis, by Route of Administration
8.1. Key Findings
8.2. Introduction
8.3. Global Veterinary Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
8.4. Global Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
8.4.1. Oral
8.4.2. Parenteral
8.4.3. Topical
8.5. Veterinary Therapeutics Market Forecast, by Route of Administration
8.6. Veterinary Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019-2027
8.7. Key Trends
9. Global Veterinary Therapeutics Market Analysis, by Distribution Channel
9.1. Key Findings
9.2. Introduction
9.3. Global Veterinary Therapeutics Market Value Share Analysis, by Distribution Channel
9.4. Global Veterinary Therapeutics Market Forecast, by Distribution Channel
9.4.1. Veterinary Hospitals
9.4.2. Veterinary Clinics
9.4.3. Pharmacies & Drug stores
9.4.4. Others
9.5. Global Veterinary Therapeutics Market Forecast, by Distribution Channel
9.6. Global Veterinary Therapeutics Market Attractiveness Analysis, by Distribution Channel
9.7. Key Trends
10. Global Veterinary Therapeutics Market Analysis, by Region
10.1. Global Veterinary Therapeutics Market Snapshot, by Country
10.2. Global Veterinary Therapeutics Market Value Share Analysis, by Region
10.3. Global Veterinary Therapeutics Market Forecast, by Region
10.3.1. North America
10.3.2. Europe
10.3.3. Asia Pacific
10.3.4. Latin America
10.3.5. Middle East & Africa
10.4. Global Veterinary Therapeutics Market Attractiveness Analysis, by Region
11. North America Veterinary Therapeutics Market Analysis
11.1. Key Findings
11.2. North America Veterinary Therapeutics Market Overview
11.3. North America Veterinary Therapeutics Market Value Share Analysis, by Product Type
11.4. North America Veterinary Therapeutics Market Forecast, by Product Type
11.4.1. Drugs
11.4.1.1. Anti-infective
11.4.1.2. Anti-inflammatory
11.4.1.3. Parasiticides
11.4.1.4. Others
11.4.2. Vaccines
11.4.2.1. Inactivated Vaccines
11.4.2.2. Live Attenuated Vaccines
11.4.2.3. Recombinant Vaccines
11.4.2.4. Others
11.4.3. Medicated Feed Additives
11.4.3.1. Antibiotics
11.4.3.2. Amino Acids
11.4.3.3. Others
11.5. North America Veterinary Therapeutics Market Value Share Analysis, by Animal
11.6. North America Veterinary Therapeutics Market Forecast, by Animal
11.6.1. Companion Animal
11.6.2. Livestock Animal
11.7. North America Veterinary Therapeutics Market Value Share Analysis, by Route of Administration
11.8. North America Veterinary Therapeutics Market Forecast, by Route of Administration
11.8.1. Oral
11.8.2. Parenteral
11.8.3. Topical
11.9. North America Veterinary Therapeutics Market Value Share Analysis, by Distribution Channel
11.10. North America Veterinary Therapeutics Market Forecast, by Distribution Channel
11.10.1. Veterinary Hospitals
11.10.2. Veterinary Clinics
11.10.3. Pharmacies & Drug Stores
11.10.4. Others
11.11. North America Veterinary Therapeutics Market Value Share Analysis, by Country
11.11.1. U.S.
11.11.2. Canada
11.12. North America Veterinary Therapeutics Market Attractiveness Analysis
11.13. Market Trends
12. Europe Veterinary Therapeutics Market Analysis
12.1. Key Findings
12.2. Europe Veterinary Therapeutics Market Overview
12.3. Europe Veterinary Therapeutics Market Value Share Analysis, by Product Type
12.4. Europe Veterinary Therapeutics Market Forecast, by Product Type
12.4.1. Drugs
12.4.1.1. Anti-infective
12.4.1.2. Anti-inflammatory
12.4.1.3. Parasiticides
12.4.1.4. Others
12.4.2. Vaccines
12.4.2.1. Inactivated Vaccines
12.4.2.2. Live Attenuated Vaccines
12.4.2.3. Recombinant Vaccines
12.4.2.4. Others
12.4.3. Medicated Feed Additives
12.4.3.1. Antibiotics
12.4.3.2. Amino Acids
12.4.3.3. Others
12.5. Europe Veterinary Therapeutics Market Value Share Analysis, by Animal
12.6. Europe Veterinary Therapeutics Market Forecast, by Animal
12.6.1. Companion Animal
12.6.2. Livestock Animal
12.7. Europe Veterinary Therapeutics Market Value Share Analysis, by Route of Administration
12.8. Europe Veterinary Therapeutics Market Forecast, by Route of Administration
12.8.1. Oral
12.8.2. Parenteral
12.8.3. Topical
12.9. Europe Veterinary Therapeutics Market Value Share Analysis, by Distribution Channel
12.10. Europe Veterinary Therapeutics Market Forecast, by Distribution Channel
12.10.1. Veterinary Hospitals
12.10.2. Veterinary Clinics
12.10.3. Pharmacies & Drug Stores
12.10.4. Others
12.11. Europe Veterinary Therapeutics Market Value Share Analysis, by Country/Sub-region
12.11.1. U.K.
12.11.2. Germany
12.11.3. Italy
12.11.4. France
12.11.5. Spain
12.11.6. Rest of Europe
12.12. Europe Veterinary Therapeutics Market Attractiveness Analysis
12.13. Market Trends
13. Asia Pacific Veterinary Therapeutics Market Analysis
13.1. Key Findings
13.2. Asia Pacific Veterinary Therapeutics Market Overview
13.3. Asia Pacific Veterinary Therapeutics Market Value Share Analysis, by Product Type
13.4. Asia Pacific Veterinary Therapeutics Market Forecast, by Product Type
13.4.1. Drugs
13.4.1.1. Anti-infective
13.4.1.2. Anti-inflammatory
13.4.1.3. Parasiticides
13.4.1.4. Others
13.4.2. Vaccines
13.4.2.1. Inactivated Vaccines
13.4.2.2. Live Attenuated Vaccines
13.4.2.3. Recombinant Vaccines
13.4.2.4. Others
13.4.3. Medicated Feed Additives
13.4.3.1. Antibiotics
13.4.3.2. Amino Acids
13.4.3.3. Others
13.5. Asia Pacific Veterinary Therapeutics Market Value Share Analysis, by Animal
13.6. Asia Pacific Veterinary Therapeutics Market Forecast, by Animal
13.6.1. Companion Animal
13.6.2. Livestock Animal
13.7. Asia Pacific Veterinary Therapeutics Market Value Share Analysis, by Route of Administration
13.8. Asia Pacific Veterinary Therapeutics Market Forecast, by Route of Administration
13.8.1. Oral
13.8.2. Parenteral
13.8.3. Topical
13.9. Asia Pacific Veterinary Therapeutics Market Value Share Analysis, by Distribution Channel
13.10. Asia Pacific Veterinary Therapeutics Market Forecast, by Distribution Channel
13.10.1. Veterinary Hospitals
13.10.2. Veterinary Clinics
13.10.3. Pharmacies & Drug Stores
13.10.4. Others
13.11. Asia Pacific Veterinary Therapeutics Market Value Share Analysis, by Country/Sub-region
13.11.1. China
13.11.2. Japan
13.11.3. India
13.11.4. Australia & New Zealand
13.11.5. Rest of Asia Pacific
13.12. Asia Pacific Veterinary Therapeutics Market Attractiveness Analysis
13.13. Market Trends
14. Latin America Veterinary Therapeutics Market Analysis
14.1. Key Findings
14.2. Latin America Veterinary Therapeutics Market Overview
14.3. Latin America Veterinary Therapeutics Market Value Share Analysis, by Product Type
14.4. Latin America Veterinary Therapeutics Market Forecast, by Product Type
14.4.1. Drugs
14.4.1.1. Anti-infective
14.4.1.2. Anti-inflammatory
14.4.1.3. Parasiticides
14.4.1.4. Others
14.4.2. Vaccines
14.4.2.1. Inactivated Vaccines
14.4.2.2. Live Attenuated Vaccines
14.4.2.3. Recombinant Vaccines
14.4.2.4. Others
14.4.3. Medicated Feed Additives
14.4.3.1. Antibiotics
14.4.3.2. Amino Acids
14.4.3.3. Others
14.5. Latin America Veterinary Therapeutics Market Value Share Analysis, by Animal
14.6. Latin America Veterinary Therapeutics Market Forecast, by Animal
14.6.1. Companion Animal
14.6.2. Livestock Animal
14.7. Latin America Veterinary Therapeutics Market Value Share Analysis, by Route of Administration
14.8. Latin America Veterinary Therapeutics Market Forecast, by Route of Administration
14.8.1. Oral
14.8.2. Parenteral
14.8.3. Topical
14.9. Latin America Veterinary Therapeutics Market Value Share Analysis, by Distribution Channel
14.10. Latin America Veterinary Therapeutics Market Forecast, by Distribution Channel
14.10.1. Veterinary Hospitals
14.10.2. Veterinary Clinics
14.10.3. Pharmacies & Drug Stores
14.10.4. Others
14.11. Latin America Veterinary Therapeutics Market Value Share Analysis, by Country/Sub-region
14.11.1. Brazil
14.11.2. Mexico
14.11.3. Rest of Latin America
14.12. Latin America Veterinary Therapeutics Market Attractiveness Analysis
14.13. Market Trends
15. Middle East & Africa Veterinary Therapeutics Market Analysis
15.1. Key Findings
15.2. Middle East & Africa Veterinary Therapeutics Market Overview
15.3. Middle East & Africa Veterinary Therapeutics Market Value Share Analysis, by Product Type
15.4. Middle East & Africa Veterinary Therapeutics Market Forecast, by Product Type
15.4.1. Drugs
15.4.1.1. Anti-infective
15.4.1.2. Anti-inflammatory
15.4.1.3. Parasiticides
15.4.1.4. Others
15.4.2. Vaccines
15.4.2.1. Inactivated Vaccines
15.4.2.2. Live Attenuated Vaccines
15.4.2.3. Recombinant Vaccines
15.4.2.4. Others
15.4.3. Medicated Feed Additives
15.4.3.1. Antibiotics
15.4.3.2. Amino Acids
15.4.3.3. Others
15.5. Middle East & Africa Veterinary Therapeutics Market Value Share Analysis, by Animal
15.6. Middle East & Africa Veterinary Therapeutics Market Forecast, by Animal
15.6.1. Companion Animal
15.6.2. Livestock Animal
15.7. Middle East & Africa Veterinary Therapeutics Market Value Share Analysis, by Route of Administration
15.8. Middle East & Africa Veterinary Therapeutics Market Forecast, by Route of Administration
15.8.1. Oral
15.8.2. Parenteral
15.8.3. Topical
15.9. Middle East & Africa Veterinary Therapeutics Market Value Share Analysis, by Distribution Channel
15.10. Middle East & Africa Veterinary Therapeutics Market Forecast, by Distribution Channel
15.10.1. Veterinary Hospitals
15.10.2. Veterinary Clinics
15.10.3. Pharmacies & Drug Stores
15.10.4. Others
15.11. Middle East & Africa Veterinary Therapeutics Market Value Share Analysis, by Country/Sub-region
15.11.1. Brazil
15.11.2. Mexico
15.11.3. Rest of Middle East & Africa
15.12. Middle East & Africa Veterinary Therapeutics Market Attractiveness Analysis
15.13. Market Trends
16. Competition Analysis
16.1. Global Veterinary Therapeutics Market Share Analysis, by Company
16.2. Competition Matrix
16.3. Company Profile
16.3.1. Boehringer Ingelheim GmbH
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Merck Animal Health
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Financial Overview
16.3.2.3. Product Portfolio
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Zoetis Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Financial Overview
16.3.3.3. Product Portfolio
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Eli Lilly and Company (Elanco Animal Health)
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Financial Overview
16.3.4.3. Product Portfolio
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Ceva Santé Animale
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Financial Overview
16.3.5.3. Product Portfolio
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Virbac
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Financial Overview
16.3.6.3. Product Portfolio
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Vetoquinol S.A.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Financial Overview
16.3.7.3. Product Portfolio
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Dechra Pharmaceuticals PLC
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Financial Overview
16.3.8.3. Product Portfolio
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Biovac
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Financial Overview
16.3.9.3. Product Portfolio
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. The Chanelle Group
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Financial Overview
16.3.10.3. Product Portfolio
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. ImmuCell Corporation
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Financial Overview
16.3.11.3. Product Portfolio
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
List of Tables
Table 01: U.S. Pet Ownership Statistics, 2017
Table 02: Cat and Dog Annual Expenditures, 2017
Table 03: United States Pet Expenditures (US$ Bn)
Table 04: Global Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 05: Global Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 06: Global Veterinary Therapeutics Market Forecast, by Vaccines, 2017–2027
Table 07: Global Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Medicated Feed Additives, 2017–2027
Table 08: Global Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Animal, 2017–2027
Table 09: Global Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 10: Global Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 11: Global Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 12: North America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 13: North America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 14: North America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Vaccines, 2017–2027
Table 15: North America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Medicated Feed Additives, 2017–2027
Table 16: North America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Animal, 2017–2027
Table 17: North America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 18: North America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 19: North America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 20: Europe Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2017–2027
Table 21: Europe Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Drugs, 2017–2027
Table 22: Europe Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Vaccines, 2017–2027
Table 23: Europe Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Medicated Feed Additives, 2017–2027
Table 24: Europe Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Animal, 2017–2027
Table 25: Europe Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 26: Europe Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 27: Europe Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 28: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2017–2027
Table 29: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Drugs, 2017–2027
Table 30: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Vaccines, 2017–2027
Table 31: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Medicated Feed Additives, 2017–2027
Table 32: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Animal, 2017–2027
Table 33: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 34: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 35: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 36: Latin America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 37: Latin America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 38: Latin America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Vaccines, 2017–2027
Table 39: Latin America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Medicated Feed Additives, 2017–2027
Table 40: Latin America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Animal, 2017–2027
Table 41: Latin America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 42: Latin America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 43: Latin America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 44: Middle East & Africa Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 45: Middle East & Africa Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 46: Middle East & Africa Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Vaccines, 2017–2027
Table 47: Middle East & Africa Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Medicated Feed Additives, 2017–2027
Table 48: Middle East & Africa Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Animal, 2017–2027
Table 49: Middle East & Africa Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 50: Middle East & Africa Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 51: Middle East & Africa Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
List of Figures
Figure 01: Global Veterinary Therapeutics Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027
Figure 02: Global Veterinary Therapeutics Market Value (US$ Mn) Forecast, 2017–2027
Figure 03: Global Veterinary Therapeutics Market Value Share, by Product Type (2018)
Figure 04: Global Veterinary Therapeutics Market Value Share, by Distribution Channel (2018)
Figure 05: Global Veterinary Therapeutics Market Value Share, by Animal (2018)
Figure 06: Global Veterinary Therapeutics Market Value Share, by Region (2018)
Figure 07: Global Veterinary Therapeutics Market Value Share, by Route of Administration (2018)
Figure 08: Global Veterinary Therapeutics Market Value Share Analysis, by Product Type, 2018 and 2027
Figure 09: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drugs, 2017–2027
Figure 10: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vaccines, 2017–2027
Figure 11: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Medicated Feed Additives, 2017–2027
Figure 12: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drugs, 2017–2027
Figure 13: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vaccine, 2017–2027
Figure 14: Global Veterinary Therapeutics Market Revenue (US$ Mn), by Medicated Feed Additives, 2017–2027
Figure 15: Veterinary Therapeutics Market Attractiveness Analysis, by Product Type, 2019-2027
Figure 16: Global Veterinary Therapeutics Market Value Share Analysis, by Animal, 2018 and 2027
Figure 17: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Companion Animal, 2017–2027
Figure 18: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Livestock Animal, 2017–2027
Figure 19: Veterinary Therapeutics Market Attractiveness Analysis, by Animal, 2019-2027
Figure 20: Global Veterinary Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
Figure 21: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oral, 2017–2027
Figure 22: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Parenteral, 2017–2027
Figure 23: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Topical, 2017–2027
Figure 24: Veterinary Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019-2027
Figure 25: Global Veterinary Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 26: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Veterinary Hospitals, 2017–2027
Figure 27: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Veterinary Clinics, 2017–2027
Figure 28: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pharmacies & Drug Stores, 2017–2027
Figure 29: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027
Figure 30: Global Veterinary Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019-2027
Figure 31: Global Veterinary Therapeutics Market Value Share Analysis, by Region, 2018 and 2027
Figure 32: Global Veterinary Therapeutics Market Attractiveness Analysis, by Region, 2019-2027
Figure 33: North America Veterinary Therapeutics Market Value (US$ Mn), 2017–2027
Figure 34: North America Veterinary Therapeutics Market Attractiveness Analysis, by Country, 2019–2027
Figure 35: North America Veterinary Therapeutics Market Value Share Analysis, by Product Type, 2018 and 2027
Figure 36: North America Veterinary Therapeutics Market Value Share Analysis, by Animal, 2018 and 2027
Figure 37: North America Veterinary Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
Figure 38: North America Veterinary Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 39: North America Veterinary Therapeutics Market Value Share Analysis, by Country, 2018 and 2027
Figure 40: North America Veterinary Therapeutics Market Attractiveness Analysis, by Product, 2019–2027
Figure 41: North America Veterinary Therapeutics Market Attractiveness Analysis, by Animal, 2019–2027
Figure 42: North America Veterinary Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019–2027
Figure 43: North America Veterinary Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 44: Europe Veterinary Therapeutics Market Value (US$ Mn) Forecast, 2017–2027
Figure 45: Europe Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
Figure 46: Europe Veterinary Therapeutics Market Value Share Analysis, by Product Type, 2018 and 2027
Figure 47: Europe Veterinary Therapeutics Market Value Share Analysis, by Animal, 2018 and 2027
Figure 48: Europe Veterinary Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
Figure 49: Europe Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 50: Europe Veterinary Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 51: Europe Veterinary Therapeutics Market Attractiveness Analysis, by Product, 2019-2027
Figure 52: Europe Veterinary Therapeutics Market Attractiveness Analysis, by Animal, 2019-2027
Figure 53: Europe Veterinary Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019-2027
Figure 54: Europe Veterinary Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019-2027
Figure 55: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, 2017–2027
Figure 56: Asia Pacific Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
Figure 57: Asia Pacific Veterinary Therapeutics Market Value Share Analysis, by Product Type, 2018 and 2027
Figure 58: Asia Pacific Veterinary Therapeutics Market Value Share Analysis, by Animal, 2018 and 2027
Figure 59: Asia Pacific Veterinary Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
Figure 60: Asia Pacific Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 61: Asia Pacific Veterinary Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 62: Asia Pacific Veterinary Therapeutics Market Attractiveness Analysis, by Product, 2019-2027
Figure 63: Asia Pacific Veterinary Therapeutics Market Attractiveness Analysis, by Animal, 2019-2027
Figure 64: Asia Pacific Veterinary Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019-2027
Figure 65: Asia Pacific Veterinary Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019-2027
Figure 66: Latin America Veterinary Therapeutics Market Value (US$ Mn) Forecast, 2017–2027
Figure 67: Latin America Veterinary Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 68: Latin America Veterinary Therapeutics Market Value Share Analysis, by Product Type, 2018 and 2027
Figure 69: Latin America Veterinary Therapeutics Market Value Share Analysis, by Animal, 2018 and 2027
Figure 70: Latin America Veterinary Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
Figure 71: Latin America Veterinary Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 72: Latin America Veterinary Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 73: Latin America Veterinary Therapeutics Market Attractiveness Analysis, by Product, 2019–2027
Figure 74: Latin America Veterinary Therapeutics Market Attractiveness Analysis, by Animal, 2019–2027
Figure 75: Latin America Veterinary Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019–2027
Figure 76: Latin America Veterinary Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 77: Middle East & Africa Veterinary Therapeutics Market Value (US$ Mn) Forecast, 2017–2027
Figure 78: Middle East & Africa Veterinary Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 79: Middle East & Africa Veterinary Therapeutics Market Value Share Analysis, by Product Type, 2018 and 2027
Figure 80: Middle East & Africa Veterinary Therapeutics Market Value Share Analysis, by Animal, 2018 and 2027
Figure 81: Middle East & Africa Veterinary Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
Figure 82: Middle East & Africa Veterinary Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 83: Middle East & Africa Veterinary Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 84: Middle East & Africa Veterinary Therapeutics Market Attractiveness Analysis, by Product Type, 2019-2027
Figure 85: Middle East & Africa Veterinary Therapeutics Market Attractiveness Analysis, by Animal, 2019-2027
Figure 86: Middle East & Africa Veterinary Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019-2027
Figure 87: Middle East & Africa Veterinary Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019-2027
Figure 88: Global Veterinary Therapeutics Market Share Analysis, by Company (2018)
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Veterinary Therapeutics Market
